SANUWAVE Health Announces Preliminary Revenue Results for the First Quarter 2024 (Ended March 31, 2024)
10. April 2024 08:30 ET
|
SANUWAVE Health, Inc.
SANUWAVE is pleased to announce preliminary revenues of $5.7 million to $5.9 million for the first quarter ended March 31, 2024. This represents the highest Q1 revenues in company history. Q1 2024...
SANUWAVE Health Announces Preliminary Revenue Results for the Third Quarter Ended September 30, 2023
10. Oktober 2023 07:30 ET
|
SANUWAVE Health, Inc.
SANUWAVE is Pleased to Announce Preliminary Revenues of $4.7 Million to $4.9 Million for the Third Quarter Ended September 30, 2023 Results Indicate 13-18% Growth Rate Over Q3 2022 UltraMist...
SANUWAVE Treats Football Legend Jim McMahon With ENERGY FIRST
22. Juli 2022 08:30 ET
|
SANUWAVE Health, Inc.
SUWANEE, GA, July 22, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – SANUWAVE Health, Inc. (OTCQB: SNWV), a Medical Device Company Specializing in Chronic Wound Care, Helps Treat Football Legend Jim...
SANUWAVE Health Announces Patent Activity from March 2021 to March 2022
20. April 2022 08:30 ET
|
SANUWAVE Health, Inc.
SANUWAVE announces patents issued over the past year SUWANEE, GA, April 20, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- SANUWAVE Health, Inc. (SNWV) focuses on the development and...
SANUWAVE® Business Update
08. April 2022 08:30 ET
|
SANUWAVE Health, Inc.
Sales Funnel and System Trials Increase 13% Month Over MonthLaunches Entry into Two New Vertical Markets; Initial Orders Exceed $1 million SUWANEE, GA, April 08, 2022 (GLOBE NEWSWIRE) -- via...
SANUWAVE Health Completes Acquisition of the Wound Care Assets of Celularity
10. August 2020 09:00 ET
|
SANUWAVE Health, Inc.
Conference Call Scheduled for Wednesday 1:00 p.m. EDT SUWANEE, GA, Aug. 10, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- SANUWAVE Health, Inc. (OTCQB: SNWV) today announced that it has...